Oxidative Stress Protection by Exogenous Delivery of rhHsp70 Chaperone to the Retinal Pigment Epithelium (RPE), a Possible Therapeutic Strategy Against RPE Degeneration

Purpose To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium. Methods Human retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical research Vol. 32; no. 1; pp. 211 - 221
Main Authors Subrizi, Astrid, Toropainen, Elisa, Ramsay, Eva, Airaksinen, Anu J., Kaarniranta, Kai, Urtti, Arto
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.01.2015
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium. Methods Human retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72 h before being exposed to 1.25 mM hydrogen peroxide. Non-treated cells served as control. We analysed interleukin 6 secretion, cell viability, and cytolysis. Uptake and intracellular distribution of fluorescently labelled rhHsp70 were investigated with flow cytometry and confocal microscopy, respectively. Ocular distribution of radioactively labelled rhHsp70 was followed ex vivo in porcine eyes by micro SPECT/CT. Results After exposure to hydrogen peroxide, IL-6 secretion decreased by 35–39% when ARPE-19 cells were pre-treated with rhHsp70. Cell viability increased by 17–32%, and cell lysis, measured by the release of lactate dehydrogenase, decreased by 6-43%. ARPE-19 cells endocytosed rhHsp70 added to the culture medium and the protein was localized in late endosomes and lysosomes. Following intravitreal injection into isolated porcine eyes, we found 20% rhHsp70 in the RPE. Conclusions Recombinant hHsp70 protein offers protection against oxidative stress. RPE cells take up the exogenously delivered rhHsp70 and localize it in late endosomes and lysosomes. This work provides the basis for a therapeutic strategy to target aggregate-associated neurodegeneration in AMD.
AbstractList Purpose: To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium. Methods: Human retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72 h before being exposed to 1.25 mM hydrogen peroxide. Non-treated cells served as control. We analysed interleukin 6 secretion, cell viability, and cytolysis. Uptake and intracellular distribution of fluorescently labelled rhHsp70 were investigated with flow cytometry and confocal microscopy, respectively. Ocular distribution of radioactively labelled rhHsp70 was followed ex vivo in porcine eyes by micro SPECT/CT. Results: After exposure to hydrogen peroxide, IL-6 secretion decreased by 35-39% when ARPE-19 cells were pre-treated with rhHsp70. Cell viability increased by 17-32%, and cell lysis, measured by the release of lactate dehydrogenase, decreased by 6-43%. ARPE-19 cells endocytosed rhHsp70 added to the culture medium and the protein was localized in late endosomes and lysosomes. Following intravitreal injection into isolated porcine eyes, we found 20% rhHsp70 in the RPE. Conclusions: Recombinant hHsp70 protein offers protection against oxidative stress. RPE cells take up the exogenously delivered rhHsp70 and localize it in late endosomes and lysosomes. This work provides the basis for a therapeutic strategy to target aggregate-associated neurodegeneration in AMD.
To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium. Human retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72 h before being exposed to 1.25 mM hydrogen peroxide. Non-treated cells served as control. We analysed interleukin 6 secretion, cell viability, and cytolysis. Uptake and intracellular distribution of fluorescently labelled rhHsp70 were investigated with flow cytometry and confocal microscopy, respectively. Ocular distribution of radioactively labelled rhHsp70 was followed ex vivo in porcine eyes by micro SPECT/CT. After exposure to hydrogen peroxide, IL-6 secretion decreased by 35-39% when ARPE-19 cells were pre-treated with rhHsp70. Cell viability increased by 17-32%, and cell lysis, measured by the release of lactate dehydrogenase, decreased by 6-43%. ARPE-19 cells endocytosed rhHsp70 added to the culture medium and the protein was localized in late endosomes and lysosomes. Following intravitreal injection into isolated porcine eyes, we found 20% rhHsp70 in the RPE. Recombinant hHsp70 protein offers protection against oxidative stress. RPE cells take up the exogenously delivered rhHsp70 and localize it in late endosomes and lysosomes. This work provides the basis for a therapeutic strategy to target aggregate-associated neurodegeneration in AMD.[PUBLICATION ABSTRACT]
Purpose To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium. Methods Human retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72 h before being exposed to 1.25 mM hydrogen peroxide. Non-treated cells served as control. We analysed interleukin 6 secretion, cell viability, and cytolysis. Uptake and intracellular distribution of fluorescently labelled rhHsp70 were investigated with flow cytometry and confocal microscopy, respectively. Ocular distribution of radioactively labelled rhHsp70 was followed ex vivo in porcine eyes by micro SPECT/CT. Results After exposure to hydrogen peroxide, IL-6 secretion decreased by 35–39% when ARPE-19 cells were pre-treated with rhHsp70. Cell viability increased by 17–32%, and cell lysis, measured by the release of lactate dehydrogenase, decreased by 6-43%. ARPE-19 cells endocytosed rhHsp70 added to the culture medium and the protein was localized in late endosomes and lysosomes. Following intravitreal injection into isolated porcine eyes, we found 20% rhHsp70 in the RPE. Conclusions Recombinant hHsp70 protein offers protection against oxidative stress. RPE cells take up the exogenously delivered rhHsp70 and localize it in late endosomes and lysosomes. This work provides the basis for a therapeutic strategy to target aggregate-associated neurodegeneration in AMD.
To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium.PURPOSETo measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium.Human retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72 h before being exposed to 1.25 mM hydrogen peroxide. Non-treated cells served as control. We analysed interleukin 6 secretion, cell viability, and cytolysis. Uptake and intracellular distribution of fluorescently labelled rhHsp70 were investigated with flow cytometry and confocal microscopy, respectively. Ocular distribution of radioactively labelled rhHsp70 was followed ex vivo in porcine eyes by micro SPECT/CT.METHODSHuman retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72 h before being exposed to 1.25 mM hydrogen peroxide. Non-treated cells served as control. We analysed interleukin 6 secretion, cell viability, and cytolysis. Uptake and intracellular distribution of fluorescently labelled rhHsp70 were investigated with flow cytometry and confocal microscopy, respectively. Ocular distribution of radioactively labelled rhHsp70 was followed ex vivo in porcine eyes by micro SPECT/CT.After exposure to hydrogen peroxide, IL-6 secretion decreased by 35-39% when ARPE-19 cells were pre-treated with rhHsp70. Cell viability increased by 17-32%, and cell lysis, measured by the release of lactate dehydrogenase, decreased by 6-43%. ARPE-19 cells endocytosed rhHsp70 added to the culture medium and the protein was localized in late endosomes and lysosomes. Following intravitreal injection into isolated porcine eyes, we found 20% rhHsp70 in the RPE.RESULTSAfter exposure to hydrogen peroxide, IL-6 secretion decreased by 35-39% when ARPE-19 cells were pre-treated with rhHsp70. Cell viability increased by 17-32%, and cell lysis, measured by the release of lactate dehydrogenase, decreased by 6-43%. ARPE-19 cells endocytosed rhHsp70 added to the culture medium and the protein was localized in late endosomes and lysosomes. Following intravitreal injection into isolated porcine eyes, we found 20% rhHsp70 in the RPE.Recombinant hHsp70 protein offers protection against oxidative stress. RPE cells take up the exogenously delivered rhHsp70 and localize it in late endosomes and lysosomes. This work provides the basis for a therapeutic strategy to target aggregate-associated neurodegeneration in AMD.CONCLUSIONSRecombinant hHsp70 protein offers protection against oxidative stress. RPE cells take up the exogenously delivered rhHsp70 and localize it in late endosomes and lysosomes. This work provides the basis for a therapeutic strategy to target aggregate-associated neurodegeneration in AMD.
To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the retinal pigment epithelium. Human retinal pigment epithelial cells (ARPE-19) were pre-treated with rhHsp70 for 24 h, 48 h, and 72 h before being exposed to 1.25 mM hydrogen peroxide. Non-treated cells served as control. We analysed interleukin 6 secretion, cell viability, and cytolysis. Uptake and intracellular distribution of fluorescently labelled rhHsp70 were investigated with flow cytometry and confocal microscopy, respectively. Ocular distribution of radioactively labelled rhHsp70 was followed ex vivo in porcine eyes by micro SPECT/CT. After exposure to hydrogen peroxide, IL-6 secretion decreased by 35-39% when ARPE-19 cells were pre-treated with rhHsp70. Cell viability increased by 17-32%, and cell lysis, measured by the release of lactate dehydrogenase, decreased by 6-43%. ARPE-19 cells endocytosed rhHsp70 added to the culture medium and the protein was localized in late endosomes and lysosomes. Following intravitreal injection into isolated porcine eyes, we found 20% rhHsp70 in the RPE. Recombinant hHsp70 protein offers protection against oxidative stress. RPE cells take up the exogenously delivered rhHsp70 and localize it in late endosomes and lysosomes. This work provides the basis for a therapeutic strategy to target aggregate-associated neurodegeneration in AMD.
Author Urtti, Arto
Subrizi, Astrid
Kaarniranta, Kai
Toropainen, Elisa
Ramsay, Eva
Airaksinen, Anu J.
Author_xml – sequence: 1
  givenname: Astrid
  surname: Subrizi
  fullname: Subrizi, Astrid
  email: astrid.subrizi@helsinki.fi
  organization: Centre for Drug Research, Division of Pharmaceutical Biosciences Faculty of Pharmacy, University of Helsinki
– sequence: 2
  givenname: Elisa
  surname: Toropainen
  fullname: Toropainen, Elisa
  organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland
– sequence: 3
  givenname: Eva
  surname: Ramsay
  fullname: Ramsay, Eva
  organization: Centre for Drug Research, Division of Pharmaceutical Biosciences Faculty of Pharmacy, University of Helsinki
– sequence: 4
  givenname: Anu J.
  surname: Airaksinen
  fullname: Airaksinen, Anu J.
  organization: Laboratory of Radiochemistry, Department of Chemistry, University of Helsinki
– sequence: 5
  givenname: Kai
  surname: Kaarniranta
  fullname: Kaarniranta, Kai
  organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, Department of Ophthalmology, Kuopio University Hospital
– sequence: 6
  givenname: Arto
  surname: Urtti
  fullname: Urtti, Arto
  organization: Centre for Drug Research, Division of Pharmaceutical Biosciences Faculty of Pharmacy, University of Helsinki, School of Pharmacy, University of Eastern Finland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25030185$$D View this record in MEDLINE/PubMed
BookMark eNqFklFrFDEUhYNU7Lb6A3yRgC8tOJpMMpPJY1lXKxS61Aq-DZnMzWzKzGSbZKT7j_ozzXSrSEF9Cly-c8_l5Byhg9GNgNBrSt5TQsSHQCmRRUYozygvyqx8hha0ECyThH8_QAsicp5VgtNDdBTCDSGkopK_QId5QRihVbFA95d3tlXR_gD8NXoIAa-9i6CjdSNudnh15zoY3RTwR-gT5XfYGew352ErCF5u1BZ8OgpHh-MG8BVEO6oer203wBjxamvTuLfTgE-u1qvTd1jhtQvBNj3g6w34pJ-i1bO5itDt8Fmn7BgiTnSyTN6JmY95iZ4b1Qd49fgeo2-fVtfL8-zi8vOX5dlFprmgMRNcCSK0acBUTBqpTWtoISnjpiwJKKIrXXFQQjBd5NAAMayRLUvTtjUG2DE62e_denc7QYj1YIOGvlcjpBhqKgpW5CKX7P9oyRnlXMoqoW-foDdu8impByqnnJSsTNSbR2pqBmjrrbeD8rv613clgO4B7VOIHsxvhJJ6rkS9r0SdKlHPlajnpeKJRtv4EGmK3Pb_VOZ7ZUguYwf-j6P_KvoJG8vLhw
CitedBy_id crossref_primary_10_1007_s00417_018_3984_y
crossref_primary_10_3390_antiox9040307
crossref_primary_10_1007_s10103_020_03036_9
crossref_primary_10_3390_jcm13133851
crossref_primary_10_1016_j_preteyeres_2016_08_001
crossref_primary_10_3390_ijms20010210
crossref_primary_10_1016_j_tiv_2022_105413
crossref_primary_10_2174_0929867326666190530122032
crossref_primary_10_3389_fphar_2024_1410998
crossref_primary_10_1016_j_tice_2023_102226
crossref_primary_10_1007_s00018_018_2843_7
crossref_primary_10_1016_j_plipres_2019_01_004
crossref_primary_10_3390_pharmaceutics11050237
crossref_primary_10_1016_j_arr_2016_02_009
crossref_primary_10_3390_pharmaceutics15010205
crossref_primary_10_1016_j_addr_2018_04_016
crossref_primary_10_1016_j_arr_2017_03_006
crossref_primary_10_1016_j_preteyeres_2016_12_001
crossref_primary_10_1208_s12248_018_0259_9
crossref_primary_10_1016_j_addr_2018_01_008
crossref_primary_10_1016_j_freeradbiomed_2016_08_002
crossref_primary_10_37867_TE1403103
crossref_primary_10_1016_j_jconrel_2015_09_065
crossref_primary_10_1016_j_jconrel_2023_01_027
crossref_primary_10_1007_s11596_019_2057_8
crossref_primary_10_1016_j_bbrep_2019_100642
crossref_primary_10_1093_advances_nmaa072
crossref_primary_10_2147_OPTH_S268322
crossref_primary_10_3390_ijms22094875
crossref_primary_10_1016_j_preteyeres_2015_09_002
crossref_primary_10_1016_j_exer_2019_107792
crossref_primary_10_1155_2020_9369524
crossref_primary_10_3390_ijms21062063
crossref_primary_10_1088_1361_6528_ac46d5
crossref_primary_10_7759_cureus_8960
crossref_primary_10_1016_j_exger_2022_111896
crossref_primary_10_3389_fnmol_2023_1230436
Cites_doi 10.1007/s00417-011-1856-9
10.1073/pnas.1018987108
10.1074/jbc.M104096200
10.1093/hmg/ddg151
10.1016/S0092-8674(00)81223-4
10.1007/BF01923466
10.1093/hmg/ddh144
10.1167/iovs.12-11571
10.1379/1466-1268(1996)001<0251:DHSRIT>2.3.CO;2
10.1016/S0896-6273(01)00177-5
10.1111/j.1365-2133.1996.tb07938.x
10.1016/j.phrs.2011.05.027
10.1016/j.ejps.2010.04.001
10.1074/jbc.M113.479253
10.1167/iovs.06-1242
10.1111/j.1582-4934.2008.00577.x
10.1167/iovs.12-10260
10.1167/iovs.05-0976
10.1056/NEJMra062326
10.4161/auto.24546
10.1167/iovs.03-0351
10.1016/j.ajo.2006.12.006
10.1023/A:1023238530504
10.1016/j.jconrel.2011.06.023
10.1016/S0014-5793(03)00605-7
10.1167/iovs.04-0311
10.2174/1568026611212220014
10.1016/j.mam.2012.03.009
10.1073/pnas.96.24.13732
10.1093/hmg/ddm057
10.1016/0022-1759(89)90397-9
10.1016/j.ajo.2012.03.047
10.1167/iovs.07-1352
10.1016/j.ces.2010.06.014
10.4161/auto.5.1.7248
10.1101/sqb.2012.76.010637
10.1016/j.ces.2014.01.005
10.1016/j.exer.2013.10.014
ContentType Journal Article
Copyright Springer Science+Business Media New York 2014
Springer Science+Business Media New York 2015
Copyright_xml – notice: Springer Science+Business Media New York 2014
– notice: Springer Science+Business Media New York 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s11095-014-1456-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Neurosciences Abstracts
ProQuest One Academic Middle East (New)

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1573-904X
EndPage 221
ExternalDocumentID 3545932361
25030185
10_1007_s11095_014_1456_6
Genre Research Support, Non-U.S. Gov't
Journal Article
Feature
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29O
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5VS
67N
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYOK
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAK
LLZTM
LSO
M1P
M4Y
MA-
MK0
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
WOW
YCJ
YLTOR
Z45
Z5O
Z7S
Z7U
Z7V
Z7W
Z7X
Z81
Z82
Z83
Z84
Z87
Z88
Z8N
Z8O
Z8P
Z8Q
Z8R
Z8V
Z8W
Z91
Z92
ZGI
ZMTXR
ZOVNA
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
PUEGO
7X8
ID FETCH-LOGICAL-c471t-74a707cfbef839f9cfdf159134f660ea0c8c84ea773c52ebe0f3b9d38c8ddffe3
IEDL.DBID 7X7
ISSN 0724-8741
1573-904X
IngestDate Tue Aug 05 10:00:12 EDT 2025
Thu Jul 10 17:34:33 EDT 2025
Sat Aug 23 13:26:44 EDT 2025
Wed Feb 19 02:15:48 EST 2025
Thu Apr 24 23:11:24 EDT 2025
Tue Jul 01 03:50:51 EDT 2025
Fri Feb 21 02:25:01 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords AMD
Protein delivery
Oxidative stress
Hsp70
RPE
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c471t-74a707cfbef839f9cfdf159134f660ea0c8c84ea773c52ebe0f3b9d38c8ddffe3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 25030185
PQID 1642140636
PQPubID 37334
PageCount 11
ParticipantIDs proquest_miscellaneous_1753527293
proquest_miscellaneous_1643144998
proquest_journals_1642140636
pubmed_primary_25030185
crossref_primary_10_1007_s11095_014_1456_6
crossref_citationtrail_10_1007_s11095_014_1456_6
springer_journals_10_1007_s11095_014_1456_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-01-01
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: United States
– name: New York
PublicationSubtitle An Official Journal of the American Association of Pharmaceutical Scientists
PublicationTitle Pharmaceutical research
PublicationTitleAbbrev Pharm Res
PublicationTitleAlternate Pharm Res
PublicationYear 2015
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Mannermaa, Reinisalo, Ranta, Vellonen, Kokki, Saarikko (CR28) 2010; 40
Glenn, Mahaffy, Dasari, Oliver, Chen, Boulton (CR27) 2012; 250
Xu, Lu, Tuomi, Jumbe, Lu, Eppler (CR34) 2013; 54
Kaarniranta, Sinha, Blasiak, Kauppinen, Vereb, Salminen (CR3) 2013; 9
Jarrett, Boulton (CR4) 2012; 33
Ryhänen, Hyttinen, Kopitz, Rilla, Kuusisto, Mannermaa (CR8) 2009; 13
de Jong (CR1) 2006; 355
CR39
Kurz, Brunk (CR23) 2009; 5
Nordgaard, Berg, Kapphahn, Reilly, Feng, Olsen (CR18) 2006; 47
Decanini, Nordgaard, Feng, Ferrington, Olsen (CR19) 2007; 143
Cowan, Diamond, Welch (CR14) 2003; 12
Paimela, Hyttinen, Viiri, Ryhänen, Karjalainen, Salminen (CR26) 2011; 64
Sherman, Goldberg (CR6) 2001; 29
Muramatsu, Hatoko, Tada, Shirai, Ohnishi (CR12) 1996; 134
Feeney-Burns, Hilderbrand, Eldridge (CR5) 1984; 25
Ninawe, Hatziavramidis, Parulekar (CR43) 2010; 65
Jiang, Moore, Zhang, Klassen, Langer, Young (CR37) 2007; 13
Strunnikova, Zhang, Teichberg, Cousins, Baffi, Becker (CR22) 2004; 45
Bailey, Kanuga, Romero, Greenwood, Luthert, Cheetham (CR25) 2004; 45
Hansen, Nielsen, Berg (CR29) 1989; 119
Locke, Tanguay (CR11) 1996; 1
CR2
Katayama, Imaizumi, Honda, Yoneda, Kudo, Takeda (CR13) 2001; 276
Glover, Lindquist (CR30) 1998; 94
Zourlidou, Gidalevitz, Kristiansen, Landles, Woodman, Wells (CR17) 2007; 16
Sakai, Kuno, Takamatsu, Kimura, Kohno, Okano (CR40) 2007; 48
CR9
Mattoo, Sharma, Priya, Finka, Goloubinoff (CR32) 2013; 288
Krohne, Liu, Holz, Meyer (CR33) 2012; 154
Hay, Sathasivam, Tobaben, Stahl, Marber, Mestril (CR16) 2004; 13
CR24
CR44
Calamini, Morimoto (CR7) 2012; 12
Wen, Li, Tsai, Lin, Li, Liu (CR15) 2003; 546
Abrishami, Ganavati, Soroush, Rouhbakhsh, Jaafari, Malaekeh-Nikouei (CR41) 2009; 29
Sreekumar, Chothe, Sharma, Baid, Kompella, Spee (CR35) 2013; 54
Goloubinoff, Mogk, Ben Zvi, Tomoyasu, Bukau (CR31) 1999; 96
Strunnikova, Baffi, Gonzalez, Silk, Cousins, Csaky (CR21) 2001; 42
Heydari, Takahashi, Gutsmann, You, Richardson (CR10) 1994; 50
Pitkänen, Ruponen, Nieminen, Urtti (CR36) 2003; 20
Nordgaard, Karunadharma, Feng, Olsen, Ferrington (CR20) 2008; 49
Checa-Casalengua, Jiang, Bravo-Osuna, Tucker, Molina-Martinez, Young (CR38) 2011; 156
Zhang, Hopkins, Heier, Birch, Halperin, Albini (CR42) 2011; 108
T Katayama (1456_CR13) 2001; 276
DG Hay (1456_CR16) 2004; 13
MB Hansen (1456_CR29) 1989; 119
TA Bailey (1456_CR25) 2004; 45
MY Sherman (1456_CR6) 2001; 29
L Feeney-Burns (1456_CR5) 1984; 25
FC Wen (1456_CR15) 2003; 546
E Mannermaa (1456_CR28) 2010; 40
1456_CR44
B Calamini (1456_CR7) 2012; 12
CL Nordgaard (1456_CR20) 2008; 49
1456_CR24
SG Jarrett (1456_CR4) 2012; 33
JR Glover (1456_CR30) 1998; 94
CL Nordgaard (1456_CR18) 2006; 47
PR Ninawe (1456_CR43) 2010; 65
A Decanini (1456_CR19) 2007; 143
T Paimela (1456_CR26) 2011; 64
K Kaarniranta (1456_CR3) 2013; 9
L Pitkänen (1456_CR36) 2003; 20
C Jiang (1456_CR37) 2007; 13
T Kurz (1456_CR23) 2009; 5
1456_CR2
1456_CR9
P Goloubinoff (1456_CR31) 1999; 96
M Abrishami (1456_CR41) 2009; 29
TU Krohne (1456_CR33) 2012; 154
PTVM Jong de (1456_CR1) 2006; 355
KJ Cowan (1456_CR14) 2003; 12
AR Heydari (1456_CR10) 1994; 50
PG Sreekumar (1456_CR35) 2013; 54
N Strunnikova (1456_CR22) 2004; 45
A Zourlidou (1456_CR17) 2007; 16
T Sakai (1456_CR40) 2007; 48
T Muramatsu (1456_CR12) 1996; 134
P Checa-Casalengua (1456_CR38) 2011; 156
N Strunnikova (1456_CR21) 2001; 42
1456_CR39
K Zhang (1456_CR42) 2011; 108
M Locke (1456_CR11) 1996; 1
JV Glenn (1456_CR27) 2012; 250
L Xu (1456_CR34) 2013; 54
T Ryhänen (1456_CR8) 2009; 13
RUH Mattoo (1456_CR32) 2013; 288
15452088 - Invest Ophthalmol Vis Sci. 2004 Oct;45(10 ):3767-77
10562656 - Mol Vis. 1999 Nov 03;5:32
19430280 - Retina. 2009 May;29(5):699-703
15115766 - Hum Mol Genet. 2004 Jul 1;13(13):1389-405
21683142 - Pharmacol Res. 2011 Nov;64(5):501-8
17360721 - Hum Mol Genet. 2007 May 1;16(9):1078-90
17591912 - Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3381-7
23737532 - J Biol Chem. 2013 Jul 19;288(29):21399-411
23339312 - Curr Top Med Chem. 2012;12(22):2623-40
10570141 - Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13732-7
2470825 - J Immunol Methods. 1989 May 12;119(2):203-10
12783846 - Hum Mol Genet. 2003 Jun 15;12(12):1377-91
21444807 - Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6241-5
19017362 - J Cell Mol Med. 2009 Sep;13(9B):3616-31
12832059 - FEBS Lett. 2003 Jul 10;546(2-3):307-14
22510306 - Mol Aspects Med. 2012 Aug;33(4):399-417
8763420 - Br J Dermatol. 1996 Jun;134(6):1035-8
9222610 - Cell Stress Chaperones. 1996 Dec;1(4):251-60
11182078 - Neuron. 2001 Jan;29(1):15-32
20385230 - Eur J Pharm Sci. 2010 Jul 11;40(4):289-96
16505012 - Invest Ophthalmol Vis Sci. 2006 Mar;47(3):815-22
7988669 - Experientia. 1994 Nov 30;50(11-12):1092-8
11481282 - Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2130-8
22371371 - Cold Spring Harb Symp Quant Biol. 2011;76:91-9
23590900 - Autophagy. 2013 Jul;9(7):973-84
24416768 - Exp Eye Res. 2013 Nov;116:359-65
22081232 - Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):349-59
21704662 - J Control Release. 2011 Nov 30;156(1):92-100
17021323 - N Engl J Med. 2006 Oct 5;355(14):1474-85
23361508 - Invest Ophthalmol Vis Sci. 2013 Mar 05;54(3):1616-24
18989099 - Autophagy. 2009 Jan;5(1):93-5
6698741 - Invest Ophthalmol Vis Sci. 1984 Feb;25(2):195-200
12739764 - Pharm Res. 2003 Apr;20(4):576-83
17960131 - Mol Vis. 2007 Sep 24;13:1783-92
14744914 - Invest Ophthalmol Vis Sci. 2004 Feb;45(2):675-84
16319820 - Mol Vis. 2005 Nov 17;11:1002-11
11551913 - J Biol Chem. 2001 Nov 16;276(46):43446-54
22818800 - Am J Ophthalmol. 2012 Oct;154(4):682-686.e2
17280640 - Am J Ophthalmol. 2007 Apr;143(4):607-15
18344451 - Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2848-55
23532520 - Invest Ophthalmol Vis Sci. 2013 Apr 17;54(4):2787-98
9674429 - Cell. 1998 Jul 10;94(1):73-82
References_xml – volume: 250
  start-page: 349
  issue: 3
  year: 2012
  end-page: 359
  ident: CR27
  article-title: Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate
  publication-title: Graefes Arch. Clin. Exp. Ophthalmol.
  doi: 10.1007/s00417-011-1856-9
– volume: 108
  start-page: 6241
  issue: 15
  year: 2011
  end-page: 6245
  ident: CR42
  article-title: Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1018987108
– volume: 276
  start-page: 43446
  issue: 46
  year: 2001
  end-page: 43454
  ident: CR13
  article-title: Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M104096200
– volume: 12
  start-page: 1377
  issue: 12
  year: 2003
  end-page: 1391
  ident: CR14
  article-title: Polyglutamine protein aggregation and toxicity are linked to the cellular stress response
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddg151
– volume: 94
  start-page: 73
  issue: 1
  year: 1998
  end-page: 82
  ident: CR30
  article-title: Hsp104, Hsp70, and Hsp40: A novel chaperone system that rescues previously aggregated proteins
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81223-4
– ident: CR39
– ident: CR2
– volume: 50
  start-page: 1092
  issue: 11–12
  year: 1994
  end-page: 1098
  ident: CR10
  article-title: Hsp70 and aging
  publication-title: Experientia
  doi: 10.1007/BF01923466
– volume: 13
  start-page: 1389
  issue: 13
  year: 2004
  end-page: 1405
  ident: CR16
  article-title: Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddh144
– volume: 54
  start-page: 2787
  issue: 4
  year: 2013
  end-page: 2798
  ident: CR35
  article-title: Antiapoptotic properties of alpha-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.12-11571
– volume: 1
  start-page: 251
  issue: 4
  year: 1996
  end-page: 260
  ident: CR11
  article-title: Diminished heat shock response in the aged myocardium
  publication-title: Cell Stress Chaperones
  doi: 10.1379/1466-1268(1996)001<0251:DHSRIT>2.3.CO;2
– volume: 42
  start-page: 2130
  issue: 9
  year: 2001
  end-page: 2138
  ident: CR21
  article-title: Regulated heat shock protein 27 expression in human retinal pigment epithelium
  publication-title: Invest. Ophthalmol. Vis. Sci.
– volume: 13
  start-page: 1783
  issue: 198–99
  year: 2007
  end-page: 1792
  ident: CR37
  article-title: Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma
  publication-title: Mol. Vis.
– volume: 29
  start-page: 15
  issue: 1
  year: 2001
  end-page: 32
  ident: CR6
  article-title: Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases
  publication-title: Neuron
  doi: 10.1016/S0896-6273(01)00177-5
– volume: 134
  start-page: 1035
  issue: 6
  year: 1996
  end-page: 1038
  ident: CR12
  article-title: Age-related decrease in the inductability of heat shock protein 72 in normal human skin
  publication-title: Br. J. Dermatol.
  doi: 10.1111/j.1365-2133.1996.tb07938.x
– volume: 64
  start-page: 501
  issue: 5
  year: 2011
  end-page: 508
  ident: CR26
  article-title: Celastrol regulates innate immunity response NF-kappa B and Hsp70 in human retinal pigment epithelial cells
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2011.05.027
– volume: 40
  start-page: 289
  issue: 4
  year: 2010
  end-page: 296
  ident: CR28
  article-title: Filter-cultured ARPE-19 cells as outer blood-retinal barrier model
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2010.04.001
– volume: 288
  start-page: 21399
  issue: 29
  year: 2013
  end-page: 21411
  ident: CR32
  article-title: Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.479253
– volume: 48
  start-page: 3381
  issue: 7
  year: 2007
  end-page: 3387
  ident: CR40
  article-title: Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.06-1242
– volume: 13
  start-page: 3616
  issue: 9B
  year: 2009
  end-page: 3631
  ident: CR8
  article-title: Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/j.1582-4934.2008.00577.x
– volume: 54
  start-page: 1616
  issue: 3
  year: 2013
  end-page: 1624
  ident: CR34
  article-title: Pharmacokinetics of ranibizumab in patients with neovascular Age-related macular degeneration: a population approach
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.12-10260
– volume: 47
  start-page: 815
  issue: 3
  year: 2006
  end-page: 822
  ident: CR18
  article-title: Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.05-0976
– ident: CR44
– volume: 355
  start-page: 1474
  issue: 14
  year: 2006
  end-page: 1485
  ident: CR1
  article-title: Mechanisms of disease: Age-related macular degeneration
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra062326
– volume: 9
  start-page: 973
  issue: 7
  year: 2013
  end-page: 984
  ident: CR3
  article-title: Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration
  publication-title: Autophagy
  doi: 10.4161/auto.24546
– volume: 45
  start-page: 675
  issue: 2
  year: 2004
  end-page: 684
  ident: CR25
  article-title: Oxidative stress affects the junctional integrity of retinal pigment epithelial cells
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.03-0351
– volume: 143
  start-page: 607
  issue: 4
  year: 2007
  end-page: 615
  ident: CR19
  article-title: Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration
  publication-title: Am J. Ophthalmol.
  doi: 10.1016/j.ajo.2006.12.006
– volume: 20
  start-page: 576
  issue: 4
  year: 2003
  end-page: 583
  ident: CR36
  article-title: Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers
  publication-title: Pharm. Res.
  doi: 10.1023/A:1023238530504
– volume: 156
  start-page: 92
  issue: 1
  year: 2011
  end-page: 100
  ident: CR38
  article-title: Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2011.06.023
– volume: 546
  start-page: 307
  issue: 2–3
  year: 2003
  end-page: 314
  ident: CR15
  article-title: Down-regulation of heat shock protein 27 in neuronal cells and non-neuronal cells expressing mutant ataxin-3
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(03)00605-7
– ident: CR9
– volume: 25
  start-page: 195
  issue: 2
  year: 1984
  end-page: 200
  ident: CR5
  article-title: Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells
  publication-title: Invest. Ophthalmol. Vis. Sci.
– volume: 45
  start-page: 3767
  issue: 10
  year: 2004
  end-page: 3777
  ident: CR22
  article-title: Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: A detailed gene expression and cellular analysis
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.04-0311
– volume: 12
  start-page: 2623
  issue: 22
  year: 2012
  end-page: 2640
  ident: CR7
  article-title: Protein homeostasis as a therapeutic target for diseases of protein conformation
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/1568026611212220014
– volume: 29
  start-page: 699
  issue: 5
  year: 2009
  end-page: 703
  ident: CR41
  article-title: Preparation, characterization, and evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration
  publication-title: Retina-J Ret Vit Dis
– volume: 33
  start-page: 399
  issue: 4
  year: 2012
  end-page: 417
  ident: CR4
  article-title: Consequences of oxidative stress in age-related macular degeneration
  publication-title: Mol Aspects Med
  doi: 10.1016/j.mam.2012.03.009
– volume: 96
  start-page: 13732
  issue: 24
  year: 1999
  end-page: 13737
  ident: CR31
  article-title: Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaperone network
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.96.24.13732
– volume: 16
  start-page: 1078
  issue: 9
  year: 2007
  end-page: 1090
  ident: CR17
  article-title: Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddm057
– volume: 119
  start-page: 203
  issue: 2
  year: 1989
  end-page: 210
  ident: CR29
  article-title: Re-examination and further development of a precise and rapid Dye method for measuring cell-growth cell kill
  publication-title: J. Immunol. Methods
  doi: 10.1016/0022-1759(89)90397-9
– volume: 154
  start-page: 682
  issue: 4
  year: 2012
  end-page: 686
  ident: CR33
  article-title: Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans
  publication-title: Am J. Ophthalmol.
  doi: 10.1016/j.ajo.2012.03.047
– volume: 49
  start-page: 2848
  issue: 7
  year: 2008
  end-page: 2855
  ident: CR20
  article-title: Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.07-1352
– ident: CR24
– volume: 65
  start-page: 5170
  issue: 18
  year: 2010
  end-page: 5177
  ident: CR43
  article-title: Delivery of drug macromolecules from thermally responsive gel implants to the posterior eye
  publication-title: Chem. Eng. Sci.
  doi: 10.1016/j.ces.2010.06.014
– volume: 5
  start-page: 93
  issue: 1
  year: 2009
  end-page: 95
  ident: CR23
  article-title: Autophagy of HSP70 and chelation of lysosomal iron in a non-redox-active form
  publication-title: Autophagy
  doi: 10.4161/auto.5.1.7248
– ident: 1456_CR2
– volume: 1
  start-page: 251
  issue: 4
  year: 1996
  ident: 1456_CR11
  publication-title: Cell Stress Chaperones
  doi: 10.1379/1466-1268(1996)001<0251:DHSRIT>2.3.CO;2
– ident: 1456_CR39
– volume: 33
  start-page: 399
  issue: 4
  year: 2012
  ident: 1456_CR4
  publication-title: Mol Aspects Med
  doi: 10.1016/j.mam.2012.03.009
– volume: 42
  start-page: 2130
  issue: 9
  year: 2001
  ident: 1456_CR21
  publication-title: Invest. Ophthalmol. Vis. Sci.
– volume: 47
  start-page: 815
  issue: 3
  year: 2006
  ident: 1456_CR18
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.05-0976
– volume: 108
  start-page: 6241
  issue: 15
  year: 2011
  ident: 1456_CR42
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1018987108
– volume: 143
  start-page: 607
  issue: 4
  year: 2007
  ident: 1456_CR19
  publication-title: Am J. Ophthalmol.
  doi: 10.1016/j.ajo.2006.12.006
– volume: 64
  start-page: 501
  issue: 5
  year: 2011
  ident: 1456_CR26
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2011.05.027
– volume: 13
  start-page: 3616
  issue: 9B
  year: 2009
  ident: 1456_CR8
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/j.1582-4934.2008.00577.x
– ident: 1456_CR9
  doi: 10.1101/sqb.2012.76.010637
– volume: 546
  start-page: 307
  issue: 2–3
  year: 2003
  ident: 1456_CR15
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(03)00605-7
– volume: 29
  start-page: 15
  issue: 1
  year: 2001
  ident: 1456_CR6
  publication-title: Neuron
  doi: 10.1016/S0896-6273(01)00177-5
– volume: 54
  start-page: 2787
  issue: 4
  year: 2013
  ident: 1456_CR35
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.12-11571
– volume: 250
  start-page: 349
  issue: 3
  year: 2012
  ident: 1456_CR27
  publication-title: Graefes Arch. Clin. Exp. Ophthalmol.
  doi: 10.1007/s00417-011-1856-9
– volume: 16
  start-page: 1078
  issue: 9
  year: 2007
  ident: 1456_CR17
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddm057
– volume: 50
  start-page: 1092
  issue: 11–12
  year: 1994
  ident: 1456_CR10
  publication-title: Experientia
  doi: 10.1007/BF01923466
– volume: 45
  start-page: 3767
  issue: 10
  year: 2004
  ident: 1456_CR22
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.04-0311
– volume: 276
  start-page: 43446
  issue: 46
  year: 2001
  ident: 1456_CR13
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M104096200
– volume: 20
  start-page: 576
  issue: 4
  year: 2003
  ident: 1456_CR36
  publication-title: Pharm. Res.
  doi: 10.1023/A:1023238530504
– volume: 13
  start-page: 1389
  issue: 13
  year: 2004
  ident: 1456_CR16
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddh144
– volume: 40
  start-page: 289
  issue: 4
  year: 2010
  ident: 1456_CR28
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2010.04.001
– volume: 288
  start-page: 21399
  issue: 29
  year: 2013
  ident: 1456_CR32
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.479253
– volume: 13
  start-page: 1783
  issue: 198–99
  year: 2007
  ident: 1456_CR37
  publication-title: Mol. Vis.
– volume: 49
  start-page: 2848
  issue: 7
  year: 2008
  ident: 1456_CR20
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.07-1352
– volume: 54
  start-page: 1616
  issue: 3
  year: 2013
  ident: 1456_CR34
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.12-10260
– volume: 5
  start-page: 93
  issue: 1
  year: 2009
  ident: 1456_CR23
  publication-title: Autophagy
  doi: 10.4161/auto.5.1.7248
– volume: 12
  start-page: 1377
  issue: 12
  year: 2003
  ident: 1456_CR14
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddg151
– ident: 1456_CR44
  doi: 10.1016/j.ces.2014.01.005
– volume: 94
  start-page: 73
  issue: 1
  year: 1998
  ident: 1456_CR30
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81223-4
– ident: 1456_CR24
  doi: 10.1016/j.exer.2013.10.014
– volume: 29
  start-page: 699
  issue: 5
  year: 2009
  ident: 1456_CR41
  publication-title: Retina-J Ret Vit Dis
– volume: 25
  start-page: 195
  issue: 2
  year: 1984
  ident: 1456_CR5
  publication-title: Invest. Ophthalmol. Vis. Sci.
– volume: 9
  start-page: 973
  issue: 7
  year: 2013
  ident: 1456_CR3
  publication-title: Autophagy
  doi: 10.4161/auto.24546
– volume: 154
  start-page: 682
  issue: 4
  year: 2012
  ident: 1456_CR33
  publication-title: Am J. Ophthalmol.
  doi: 10.1016/j.ajo.2012.03.047
– volume: 12
  start-page: 2623
  issue: 22
  year: 2012
  ident: 1456_CR7
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/1568026611212220014
– volume: 48
  start-page: 3381
  issue: 7
  year: 2007
  ident: 1456_CR40
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.06-1242
– volume: 45
  start-page: 675
  issue: 2
  year: 2004
  ident: 1456_CR25
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.03-0351
– volume: 65
  start-page: 5170
  issue: 18
  year: 2010
  ident: 1456_CR43
  publication-title: Chem. Eng. Sci.
  doi: 10.1016/j.ces.2010.06.014
– volume: 156
  start-page: 92
  issue: 1
  year: 2011
  ident: 1456_CR38
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2011.06.023
– volume: 355
  start-page: 1474
  issue: 14
  year: 2006
  ident: 1456_CR1
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra062326
– volume: 119
  start-page: 203
  issue: 2
  year: 1989
  ident: 1456_CR29
  publication-title: J. Immunol. Methods
  doi: 10.1016/0022-1759(89)90397-9
– volume: 96
  start-page: 13732
  issue: 24
  year: 1999
  ident: 1456_CR31
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.96.24.13732
– volume: 134
  start-page: 1035
  issue: 6
  year: 1996
  ident: 1456_CR12
  publication-title: Br. J. Dermatol.
  doi: 10.1111/j.1365-2133.1996.tb07938.x
– reference: 18989099 - Autophagy. 2009 Jan;5(1):93-5
– reference: 8763420 - Br J Dermatol. 1996 Jun;134(6):1035-8
– reference: 21683142 - Pharmacol Res. 2011 Nov;64(5):501-8
– reference: 17960131 - Mol Vis. 2007 Sep 24;13:1783-92
– reference: 11551913 - J Biol Chem. 2001 Nov 16;276(46):43446-54
– reference: 17591912 - Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3381-7
– reference: 6698741 - Invest Ophthalmol Vis Sci. 1984 Feb;25(2):195-200
– reference: 22371371 - Cold Spring Harb Symp Quant Biol. 2011;76:91-9
– reference: 21444807 - Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6241-5
– reference: 17360721 - Hum Mol Genet. 2007 May 1;16(9):1078-90
– reference: 2470825 - J Immunol Methods. 1989 May 12;119(2):203-10
– reference: 23590900 - Autophagy. 2013 Jul;9(7):973-84
– reference: 11481282 - Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2130-8
– reference: 21704662 - J Control Release. 2011 Nov 30;156(1):92-100
– reference: 14744914 - Invest Ophthalmol Vis Sci. 2004 Feb;45(2):675-84
– reference: 12783846 - Hum Mol Genet. 2003 Jun 15;12(12):1377-91
– reference: 15115766 - Hum Mol Genet. 2004 Jul 1;13(13):1389-405
– reference: 12739764 - Pharm Res. 2003 Apr;20(4):576-83
– reference: 23532520 - Invest Ophthalmol Vis Sci. 2013 Apr 17;54(4):2787-98
– reference: 17280640 - Am J Ophthalmol. 2007 Apr;143(4):607-15
– reference: 22081232 - Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):349-59
– reference: 9222610 - Cell Stress Chaperones. 1996 Dec;1(4):251-60
– reference: 22510306 - Mol Aspects Med. 2012 Aug;33(4):399-417
– reference: 22818800 - Am J Ophthalmol. 2012 Oct;154(4):682-686.e2
– reference: 16319820 - Mol Vis. 2005 Nov 17;11:1002-11
– reference: 20385230 - Eur J Pharm Sci. 2010 Jul 11;40(4):289-96
– reference: 12832059 - FEBS Lett. 2003 Jul 10;546(2-3):307-14
– reference: 11182078 - Neuron. 2001 Jan;29(1):15-32
– reference: 24416768 - Exp Eye Res. 2013 Nov;116:359-65
– reference: 19430280 - Retina. 2009 May;29(5):699-703
– reference: 10562656 - Mol Vis. 1999 Nov 03;5:32
– reference: 17021323 - N Engl J Med. 2006 Oct 5;355(14):1474-85
– reference: 23737532 - J Biol Chem. 2013 Jul 19;288(29):21399-411
– reference: 7988669 - Experientia. 1994 Nov 30;50(11-12):1092-8
– reference: 18344451 - Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2848-55
– reference: 10570141 - Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13732-7
– reference: 19017362 - J Cell Mol Med. 2009 Sep;13(9B):3616-31
– reference: 23339312 - Curr Top Med Chem. 2012;12(22):2623-40
– reference: 9674429 - Cell. 1998 Jul 10;94(1):73-82
– reference: 15452088 - Invest Ophthalmol Vis Sci. 2004 Oct;45(10 ):3767-77
– reference: 16505012 - Invest Ophthalmol Vis Sci. 2006 Mar;47(3):815-22
– reference: 23361508 - Invest Ophthalmol Vis Sci. 2013 Mar 05;54(3):1616-24
SSID ssj0008194
Score 2.334141
Snippet Purpose To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in...
To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in the...
Purpose: To measure the cytoprotective effects of rhHsp70 against oxidative stress and study its cellular uptake, intracellular and intraocular distribution in...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 211
SubjectTerms Animals
Biochemistry
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Biomedicine
Cell Culture Techniques
Cell Line
Cell Survival - drug effects
Cellular biology
Heat shock proteins
HSP70 Heat-Shock Proteins - administration & dosage
HSP70 Heat-Shock Proteins - pharmacokinetics
HSP70 Heat-Shock Proteins - therapeutic use
Humans
Hydrogen Peroxide - toxicity
Interleukin-6 - secretion
Intravitreal Injections
Macular Degeneration - immunology
Macular Degeneration - metabolism
Macular Degeneration - pathology
Macular Degeneration - prevention & control
Medical Law
Oxidative stress
Oxidative Stress - drug effects
Pharmaceutical sciences
Pharmacology/Toxicology
Pharmacy
Recombinant Proteins
Research Paper
Retina
Retinal Pigment Epithelium - drug effects
Retinal Pigment Epithelium - immunology
Retinal Pigment Epithelium - metabolism
Retinal Pigment Epithelium - pathology
Swine
Tissue Distribution
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFBZb97KXsfuyduMMRtklAtmSLecxrClhsM10DfTNyLKUBbI4JCnU_6g_c-f4krR0LfTVPomP-XSkT5fvM2Mfc2FCE9qCY-cYcZUIxwfSel44YRKX0OoY6Z1__IzHE_X9LDprddzr7rR7tyVZ99Q7sVsgSE0cKB7gqM_jh-xRhFN3Osc1CYfb7heHuNozSocKS10F3Vbm__7i-mB0g2He2B2tB53jp-xJyxZh2MD7jD1wi-fsMG3spqs-nO7UU-s-HEK6M6KuXrDLXxezojb2ht-1JATSxpUBsYC8gtFF2Vi0wpGb0_mMCkoPqz_j9VILIGWCW5ULB5sSkCbCCamjMZt0NqUlRRgtSc8xn53_hU8n6ehzHwykJdXY3F3NDFoH3AqGUzNDOgoYjY-c1o7XlMxLNjkenX4b8_bLDNziYLbhWhkttPW580iw_MD6wiMvCqTycSycETaxiXJGa2mjENuJ8DIfFBKvFoX3Tr5iewt8gTcMkE64QeAVQumV9So3MjY6NB5htNaqHhMdRJltbcvp6xnzbGe4TKhmiGpGqGZxj33Z_mTZeHbcFXzQ4Z615bvOApL_ItWRePvD9jYWHu2mmIVDZChG4mwUp6t3xGhyz8H5i-yx102b2maE3BM71yTqsa9dI7uSwG3pvr1X9D57jAQvapaMDtjeZnXu3iGJ2uTv66L5B5hXFRg
  priority: 102
  providerName: Springer Nature
Title Oxidative Stress Protection by Exogenous Delivery of rhHsp70 Chaperone to the Retinal Pigment Epithelium (RPE), a Possible Therapeutic Strategy Against RPE Degeneration
URI https://link.springer.com/article/10.1007/s11095-014-1456-6
https://www.ncbi.nlm.nih.gov/pubmed/25030185
https://www.proquest.com/docview/1642140636
https://www.proquest.com/docview/1643144998
https://www.proquest.com/docview/1753527293
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bjtMwELVg94UXxJ3AshoktOLSaJ3EufQJtZBSgShR2UrlKXIcu1QqTWm70uaP-ExmcmkXrehTpMRVppoZz_E455ixVxmXrnRVbuPk6Nsi4truesrYueYy0hF1x4jv_HUUDCfi89SfNg23TfNZZTsnVhN1XijqkZ87xMjE6uMF71e_bTo1inZXmyM0brNjki6jqA6nuwUXVbtKPip0BWa9cNpdzYo653DiJjvCdhBD2MG_dekG2LyxUVrVn8E9drcBjtCrPX2f3dLLB-wsqZWnyw5c7IlUmw6cQbLXpC4fsj_fruZ5pfEN3yt2CCS1QAO6BbIS4quiVmuFj3pBn2qUUBhY_xxuViEHIinodbHUsC0AESOMiSiN1iTzGXUXIV4RtWMxv_wFr8dJ_KYDEpKC0m2hr1sGjRhuCb2ZnCMyBRyNr5xV4tdkzCM2GcQXH4Z2c0iDrbCube1QyJCHymTaINYyXWVygxDJ8YQJAq4lV5GKhJZh6CnfxZDhxsu6uYd389wY7T1mR0v8A08ZILLQXccI3-VGKCMy6QUydKVBNyqlhMV466JUNQrmdJDGIt1rL5NXU_RqSl5NA4u93f1kVct3HBp80vo9bTJ5k-7jzmIvd48xB2ljRS41eobGeLgwxZXrgTEhCengUsaz2JM6pnYWIQzFeTbyLfauDbJrBvzP3GeHzX3O7iC48-t20Qk72q4v9QsEUNvstMqSU3bcG_T7I7p--vElxms_HiVjfDpxe38B_30eGA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VcoAL4o2hwCBBxSMr1vb6kQNCFU2V0gdWSaXczHq9GyKFOCSpqP8RJ34jM3acFFXk1mu8dsaa2Zlvdv19y9jLTChPeTrnmBwDLmNheNvXludGqNjEtDpGfOej47B7Kj_3g_4G-9NwYeizyiYnVok6LzStkb93iZGJ1ccPP05-cjo1inZXmyM06rA4MOUvbNlmH_Z30b-vPG-v0_vU5YtTBbjGRDznkVSRiLTNjEVwYNva5hZruutLG4bCKKFjHUujosjXgYfvKKyftXMff81za42Pz73GrmPhFdTsRf1lg0fVtZKrijyJWUa6zS5qRdVzBXGhXcldxCw8_LcOXgK3lzZmq3q3d5vdWgBV2Kkj6w7bMOO7bDupla7LFvRWxK1ZC7YhWWlgl_fY7y_nw7zSFIevFRsFkloQAsMAshI650WtDgu7ZkSfhpRQWJh-784mkQAiRZhpMTYwLwARKpwQMRutSYYDWs2EzoSoJKPh2Q94fZJ03rRAQVLQ9B6Zi5bBQny3hJ2BGiISBhyNfzmoxLbJmPvs9Erc94BtjvEFHjFAJGParpWBJ6zUVmbKD1XkKYtu1FpLh4nGRaleKKbTwR2jdKX1TF5N0aspeTUNHfZ2ecuklgtZN3ir8Xu6yByzdBXnDnuxvIxznjZy1NigZ2iMj40wdsprxkQk3IOtk--wh3VMLS1C2It5PQ4c9q4JsgsG_M_cx-vNfc5udHtHh-nh_vHBE3YTgWVQL1Vtsc359Mw8RfA2z55VMwbYt6ueon8BFX1YAA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2VVEK8IO4ECgwSVFxidW2vL3lAqJBEKYVgpa3UN7Ne74ZIIQ5JKuo_4hv4OmZ8SYoq8tbXZJ2MNbMzZ3b3nGXsRcKlIx2VWpgcPUuEXFttVxkr1VyGOqTVMeI7fxn4_RPx6dQ73WJ_ai4MHausc2KRqNNM0Rr5nk2MTKw-rr9nqmMRUaf3fvbTohukaKe1vk6jDJFDnf_C9m3x7qCDvn7pOL3u8ce-Vd0wYClMyksrEDLggTKJNggUTFuZ1GB9t11hfJ9ryVWoQqFlELjKc_B9uXGTdurip2lqjHbxd6-x7YC6ogbb_tAdRMNVHcBaW4hXBY7AnCPsek-1IO7ZnJjRtrBsRDCW_29VvAR1L23TFtWvd4vdrGAr7Jdxdptt6ekdthuVutd5C47XNK5FC3YhWiti53fZ76_n47RQGIejgpsCUSkPgUEBSQ7d86zUioWOntBBkRwyA_Pv_cUs4EAUCT3PphqWGSBehSHRtNGaaDyitU3ozohYMhmf_YBXw6j7ugUSoowm-0RftAwqKd4c9kdyjLgYcDT-5aiQ3iZj7rGTK3HgfdaY4gs8ZIC4RrdtIzyHG6GMSKTry8CRBt2olBJNxmsXxarST6drPCbxWvmZvBqjV2Pyauw32ZvVI7NSPGTT4J3a73GVRxbxOuqb7Pnqa8wAtK0jpxo9Q2NcbIuxb94wJiAZH2yk3CZ7UMbUyiIEwZjlQ6_J3tZBdsGA_5n7aLO5z9h1nJ7x54PB4WN2A1GmV65b7bDGcn6mnyCSWyZPqykD7NtVz9K_69Bdmw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxidative+stress+protection+by+exogenous+delivery+of+rhHsp70+chaperone+to+the+retinal+pigment+epithelium+%28RPE%29%2C+a+possible+therapeutic+strategy+against+RPE+degeneration&rft.jtitle=Pharmaceutical+research&rft.au=Subrizi%2C+Astrid&rft.au=Toropainen%2C+Elisa&rft.au=Ramsay%2C+Eva&rft.au=Airaksinen%2C+Anu+J&rft.date=2015-01-01&rft.issn=1573-904X&rft.eissn=1573-904X&rft.volume=32&rft.issue=1&rft.spage=211&rft_id=info:doi/10.1007%2Fs11095-014-1456-6&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0724-8741&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0724-8741&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0724-8741&client=summon